Emas Pharma was established in 1998, initially to enable US biotech and pharma companies to develop medicinal products and medical devices in Europe. From these beginnings, we derived our original name: European Medical Advisory Services (EMAS).
Following the success of our European operations, we expanded our services worldwide and our global and regional operations are now named Emas Pharma. Our mission is to provide support to the pharmaceutical and biotech industry in the development and commercialisation of products worldwide. We undertake to deliver the highest quality service whilst retaining flexibility and value that our customers have come to rely on.
We bring decades of experience in medicines development and commercialisation at global, regional and national levels. We have the expertise to see things from big pharma, small pharma, biotech and regulatory authority perspectives and this has given us a track record of success in designing and implementing clinical research, medical affairs, pharmacovigilance and regulatory activities worldwide.
We help drive pharmaceutical and biotech product development from first into man right the way through to the end of the product lifecycle. Available separately or as part of a comprehensive strategic programme, our Clinical Operations, Pharmacovigilance, Regulatory Affairs, Medical and Scientific Services and Quality Assurance groups can provide a tailored package to support you.